Review of NIOSH Cannabis-Related Health Hazard Evaluations and Research
- PMID: 32053725
- PMCID: PMC7416426
- DOI: 10.1093/annweh/wxaa013
Review of NIOSH Cannabis-Related Health Hazard Evaluations and Research
Abstract
Since 2004, the National Institute for Occupational Safety and Health (NIOSH) has received 10 cannabis-related health hazard evaluation (HHE) investigation requests from law enforcement agencies (n = 5), state-approved cannabis grow operations (n = 4), and a coroner's office (n = 1). Earlier requests concerned potential illicit drug exposures (including cannabis) during law enforcement activities and criminal investigations. Most recently HHE requests have involved state-approved grow operations with potential occupational exposures during commercial cannabis production for medicinal and non-medical (recreational) use. As of 2019, the United States Drug Enforcement Administration has banned cannabis as a Schedule I substance on the federal level. However, cannabis legalization at the state level has become more common in the USA. In two completed cannabis grow operation HHE investigations (two investigations are still ongoing as of 2019), potential dermal exposures were evaluated using two distinct surface wipe sample analytical methods. The first analyzed for delta-9-tetrahydrocannabinol (Δ9-THC) using a liquid chromatography and tandem mass spectrometry (LC-MS-MS) method with a limit of detection (LOD) of 4 nanograms (ng) per sample. A second method utilized high performance liquid chromatography with diode-array detection to analyze for four phytocannabinoids (Δ9-THC, Δ9-THC acid, cannabidiol, and cannabinol) with a LOD (2000 ng per sample) which, when comparing Δ9-THC limits, was orders of magnitude higher than the LC-MS-MS method. Surface wipe sampling results for both methods illustrated widespread contamination of all phytocannabinoids throughout the tested occupational environments, highlighting the need to consider THC form (Δ9-THC or Δ9-THC acid) as well as other biologically active phytocannabinoids in exposure assessments. In addition to potential cannabis-related dermal exposures, ergonomic stressors, and psychosocial issues, the studies found employees in cultivation, harvesting, and processing facilities could potentially be exposed to allergens and respiratory hazards through inhalation of organic dusts (including fungus, bacteria, and endotoxin) and volatile organic compounds (VOCs) such as diacetyl and 2,3-pentanedione. These hazards were most evident during the decarboxylation and grinding of dried cannabis material, where elevated job-specific concentrations of VOCs and endotoxin were generated. Additionally, utilization of contemporary gene sequencing methods in NIOSH HHEs provided a more comprehensive characterization of microbial communities sourced during cannabis cultivation and processing. Internal Transcribed Spacer region sequencing revealed over 200 fungal operational taxonomic units and breathing zone air samples were predominantly composed of Botrytis cinerea, a cannabis plant pathogen. B. cinerea, commonly known as gray mold within the industry, has been previously associated with hypersensitivity pneumonitis. This work elucidates new occupational hazards related to cannabis production and the evolving occupational safety and health landscape of an emerging industry, provides a summary of cannabis-related HHEs, and discusses critical lessons learned from these previous HHEs.
Keywords: 2,3-pentanedione; allergen; cannabis; delta-9-tetrahydrocannabinol; diacetyl; endotoxin; marijuana; mold; volatile organic compounds; Δ9-THC.
Published by Oxford University Press on behalf of The British Occupational Hygiene Society 2020.
Conflict of interest statement
Conflict of interest
The authors do not have any conflict of interest regarding this research and the cannabis industry.
Similar articles
-
Potential occupational and respiratory hazards in a Minnesota cannabis cultivation and processing facility.Am J Ind Med. 2019 Oct;62(10):874-882. doi: 10.1002/ajim.23025. Epub 2019 Jul 23. Am J Ind Med. 2019. PMID: 31332812 Free PMC article.
-
Occupational Exposure to Secondhand Cannabis Smoke Among Law Enforcement Officers Providing Security at Outdoor Concert Events.Ann Work Expo Health. 2020 Aug 6;64(7):705-714. doi: 10.1093/annweh/wxaa025. Ann Work Expo Health. 2020. PMID: 32219297 Free PMC article.
-
Microbial hazards during harvesting and processing at an outdoor United States cannabis farm.J Occup Environ Hyg. 2018 May;15(5):430-440. doi: 10.1080/15459624.2018.1432863. J Occup Environ Hyg. 2018. PMID: 29370578 Free PMC article.
-
Occupational health and safety in cannabis production: an Australian perspective.Int J Occup Environ Health. 2018 Jul-Oct;24(3-4):75-85. doi: 10.1080/10773525.2018.1517234. Epub 2018 Oct 3. Int J Occup Environ Health. 2018. PMID: 30281413 Free PMC article. Review.
-
Evaluation of an Occupational Safety and Health Training for Cannabis Cultivation Workers.Ann Work Expo Health. 2020 Aug 6;64(7):765-769. doi: 10.1093/annweh/wxaa026. Ann Work Expo Health. 2020. PMID: 32185387 Free PMC article. Review.
Cited by
-
A 20-Year-Old Man with e-Cigarette or Vaping Product Use-Associated Lung Injury (EVALI) and Thrombotic Coagulopathy.Am J Case Rep. 2021 Apr 15;22:e929915. doi: 10.12659/AJCR.929915. Am J Case Rep. 2021. PMID: 33854029 Free PMC article.
-
Fatal Occupational Asthma in Cannabis Production - Massachusetts, 2022.MMWR Morb Mortal Wkly Rep. 2023 Nov 17;72(46):1257-1261. doi: 10.15585/mmwr.mm7246a2. MMWR Morb Mortal Wkly Rep. 2023. PMID: 37971937 Free PMC article.
-
Identification of minimum essential therapeutic mixtures from cannabis plant extracts by screening in cell and animal models of Parkinson's disease.Front Pharmacol. 2022 Oct 5;13:907579. doi: 10.3389/fphar.2022.907579. eCollection 2022. Front Pharmacol. 2022. PMID: 36278152 Free PMC article.
-
IgE-Mediated Cannabis Allergy and Cross-Reactivity Syndromes: A Roadmap for Correct Diagnosis and Management.Curr Allergy Asthma Rep. 2024 Aug;24(8):407-414. doi: 10.1007/s11882-024-01159-5. Epub 2024 Jul 11. Curr Allergy Asthma Rep. 2024. PMID: 38990404 Review.
-
The Emerging Spectrum of Respiratory Diseases in the U.S. Cannabis Industry.Semin Respir Crit Care Med. 2023 Jun;44(3):405-414. doi: 10.1055/s-0043-1766116. Epub 2023 Apr 4. Semin Respir Crit Care Med. 2023. PMID: 37015286 Free PMC article.
References
-
- Agriculture Improvement Act of 2018. In H.R. 2—S. 3042—115th Congress. Available at https://www.congress.gov/bill/115th-congress/senate-bill/3042/text?forma.... Accessed 3 February 2020.
-
- Ambach L, Penitschka F, Broillet A et al. (2014) Simultaneous quantification of delta-9-THC, THC-acid A, CBN and CBD in seized drugs using HPLC-DAD. Forensic Sci Int; 243: 107–11. - PubMed
-
- Ampere A, Delhaes L, Soots J et al. (2012) Hypersensitivity pneumonitis induced by Shiitake mushroom spores. Med Mycol; 50: 654–7. - PubMed
MeSH terms
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials